| Neal E Little, MD | |
|
775 S Main St, Chelsea, MI 48118-1370 | |
| (734) 475-1311 | |
| Not Available |
| Full Name | Neal E Little |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine - Emergency Medical Services |
| Location | 775 S Main St, Chelsea, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1346278371 | NPI | - | NPPES |
| 103150727 | Medicaid | MI | |
| 104441415 | Medicaid | MI | |
| NL035352 | Other | MI | BLUE SHIELD |
| 103228051 | Medicaid | MI | |
| 102742607 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207PE0004X | Emergency Medicine - Emergency Medical Services | 035352 (Michigan) | Primary |
| Entity Name | Chelsea Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912947409 PECOS PAC ID: 0648171074 Enrollment ID: O20040119000004 |
News Archive
Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today financial results for the second quarter ended April 30, 2011.
CSG Partners, LLC, served as the exclusive financial advisor to Home Medical Equipment, on its recent transition to becoming 100% owned by its Employee Stock Ownership Plan (ESOP).
BioTime, Inc. announced today that it has initiated shipments of stem cell research products to its worldwide distributor, Millipore Corporation, according to the terms of the co-marketing agreement between the two companies that was announced on July 9, 2009. BioTime has shipped inventory of six ACTCellerate™ progenitor cell lines to Millipore and plans to begin shipments of additional cell lines and ESpan™ cell growth media in the next several weeks.
Some patients with metastatic prostate cancer respond to a combination of immune checkpoint inhibitors after hormonal therapy and chemotherapy have failed, according to early results from a clinical trial led by investigators at The University of Texas MD Anderson Cancer Center presented today at the American Society of Clinical Oncology Genitourinary Cancers Symposium in San Francisco.
Pediatric and Developmental Pathology - Gonadal dysgenesis—defective development of the ovaries or testes— may also bring with it an increased risk of gonadal tumors. A recent discovery at the histologic level could help identify cells at risk of conversion into a tumor.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Neal E Little, MD 2000 Green Rd, Suite 300, Ann Arbor, MI 48105-1598 Ph: () - | Neal E Little, MD 775 S Main St, Chelsea, MI 48118-1370 Ph: (734) 475-1311 |
News Archive
Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, announced today financial results for the second quarter ended April 30, 2011.
CSG Partners, LLC, served as the exclusive financial advisor to Home Medical Equipment, on its recent transition to becoming 100% owned by its Employee Stock Ownership Plan (ESOP).
BioTime, Inc. announced today that it has initiated shipments of stem cell research products to its worldwide distributor, Millipore Corporation, according to the terms of the co-marketing agreement between the two companies that was announced on July 9, 2009. BioTime has shipped inventory of six ACTCellerate™ progenitor cell lines to Millipore and plans to begin shipments of additional cell lines and ESpan™ cell growth media in the next several weeks.
Some patients with metastatic prostate cancer respond to a combination of immune checkpoint inhibitors after hormonal therapy and chemotherapy have failed, according to early results from a clinical trial led by investigators at The University of Texas MD Anderson Cancer Center presented today at the American Society of Clinical Oncology Genitourinary Cancers Symposium in San Francisco.
Pediatric and Developmental Pathology - Gonadal dysgenesis—defective development of the ovaries or testes— may also bring with it an increased risk of gonadal tumors. A recent discovery at the histologic level could help identify cells at risk of conversion into a tumor.
› Verified 9 days ago
Robert M Carruthers, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 775 S Main St, Chelsea, MI 48118 Phone: 734-475-1311 | |
David Kaisler, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 775 S Main St, Chelsea, MI 48118 Phone: 734-475-1311 | |
Barry M Nemon, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 775 S Main St, Chelsea, MI 48118 Phone: 734-475-1311 | |
Merle A Hunter, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 775 S Main St, Chelsea, MI 48118 Phone: 734-475-1311 | |
Susan B Sullivan, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 775 S Main St, Chelsea, MI 48118 Phone: 734-475-1311 | |
Patrick B Munson, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 775 S Main St, Chelsea, MI 48118 Phone: 734-475-1311 |